{"id":7479,"date":"2020-01-10T20:03:00","date_gmt":"2020-01-11T04:03:00","guid":{"rendered":"https:\/\/www.sfj-pharma.com\/?p=7479"},"modified":"2021-05-13T14:04:26","modified_gmt":"2021-05-13T22:04:26","slug":"phas-stock-rockets-25-on-collaboration-with-sfj-pharma","status":"publish","type":"post","link":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/","title":{"rendered":"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma"},"content":{"rendered":"\r\n<p>In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (<a href=\"https:\/\/microsmallcap.com\/stock-quote\/PHAS\/quote\" target=\"_blank\" rel=\"noreferrer noopener\">NASDAQ:PHAS<\/a>) announced that it has reached a major agreement with SFJ Pharmaceuticals.<\/p>\r\n\r\n\r\n\r\n<p><strong>Important Collaboration<\/strong><\/p>\r\n\r\n\r\n\r\n<p>The company announced today that it\u00a0<a href=\"https:\/\/seekingalpha.com\/pr\/17745559-phasebio-announces-financing-and-co-development-collaboration-sfj-pharmaceuticals-for-pb2452\" target=\"_blank\" rel=\"noreferrer noopener\">reached a collaboration<\/a>\u00a0and financing agreement with SFJ, which has had a major effect on PhaseBio\u2019s stock this morning.<\/p>\r\n\r\n\r\n\r\n<p>The agreement is in relation to the PhaseBio product PB2452, which is supposed to work as a reversal agent for the antiplatelet therapy ticagrelor.<\/p>\r\n\r\n\r\n\r\n<p>As a result, PHAS stock has emerged as one of the major gainers in the market this morning and will likely be monitored closely by market participants for the rest of the day. According to the agreement that has been signed between the two companies, SFJ Pharmaceuticals is going to provide funds to the tune of $120 million for the development of PB2452.<\/p>\r\n\r\n\r\n\r\n<p>After the news broke, PHAS stock\u00a0<a href=\"https:\/\/finance.yahoo.com\/quote\/PHAS\" target=\"_blank\" rel=\"noreferrer noopener\">went up<\/a>\u00a0by as much as 25% to $7.05.<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>SFJ is also going to be responsible for all regulatory activities that take place outside the United States. As much as $90 million has been earmarked for expenses related to the development of the product until 2021.<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>The residual $30 million is going to be paid out after certain milestones are met. This is a significant deal for PhaseBio Pharmaceuticals, and the rally in PHAS stock should not come as a surprise.<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>Jonathon P. Mow, the Chief Executive Officer of PhaseBio, said of the deal:\u00a0<em>\u201cThis innovative collaboration with SFJ provides PhaseBio with substantial funding to continue the rapid advancement of our lead program, PB2452.\u201d<\/em><\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>He went on to add that the deal is also going to greatly expand the global reach of the product. Investors could do well by having PHAS stock in their watch lists.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that it\u00a0reached a collaboration\u00a0and financing agreement with SFJ, which has had&#8230;<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[103],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PHAS Stock Rockets 25% on Collaboration With SFJ Pharma - SFJ Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma - SFJ Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that it\u00a0reached a collaboration\u00a0and financing agreement with SFJ, which has had...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"SFJ Pharmaceuticals\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-11T04:03:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-13T22:04:26+00:00\" \/>\n<meta name=\"author\" content=\"Lily Xu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lily Xu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\"},\"author\":{\"name\":\"Lily Xu\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/770e5cbce35f5f0f90d2218806ceba11\"},\"headline\":\"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma\",\"datePublished\":\"2020-01-11T04:03:00+00:00\",\"dateModified\":\"2021-05-13T22:04:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\"},\"wordCount\":302,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\",\"url\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\",\"name\":\"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma - SFJ Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#website\"},\"datePublished\":\"2020-01-11T04:03:00+00:00\",\"dateModified\":\"2021-05-13T22:04:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sfj-pharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#website\",\"url\":\"https:\/\/www.sfj-pharma.com\/\",\"name\":\"SFJ Pharmaceuticals\",\"description\":\"Resources for Accelerated Clinical Development\",\"publisher\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sfj-pharma.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\",\"name\":\"SFJ Pharmaceuticals\",\"url\":\"https:\/\/www.sfj-pharma.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552\",\"contentUrl\":\"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552\",\"width\":750,\"height\":205,\"caption\":\"SFJ Pharmaceuticals\"},\"image\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/770e5cbce35f5f0f90d2218806ceba11\",\"name\":\"Lily Xu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2b733936c0f668be1f942765f61e3056?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2b733936c0f668be1f942765f61e3056?s=96&d=mm&r=g\",\"caption\":\"Lily Xu\"},\"url\":\"https:\/\/www.sfj-pharma.com\/author\/lily\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma - SFJ Pharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/","og_locale":"en_US","og_type":"article","og_title":"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma - SFJ Pharmaceuticals","og_description":"In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that it\u00a0reached a collaboration\u00a0and financing agreement with SFJ, which has had...","og_url":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/","og_site_name":"SFJ Pharmaceuticals","article_published_time":"2020-01-11T04:03:00+00:00","article_modified_time":"2021-05-13T22:04:26+00:00","author":"Lily Xu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lily Xu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#article","isPartOf":{"@id":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/"},"author":{"name":"Lily Xu","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/770e5cbce35f5f0f90d2218806ceba11"},"headline":"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma","datePublished":"2020-01-11T04:03:00+00:00","dateModified":"2021-05-13T22:04:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/"},"wordCount":302,"commentCount":0,"publisher":{"@id":"https:\/\/www.sfj-pharma.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/","url":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/","name":"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma - SFJ Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.sfj-pharma.com\/#website"},"datePublished":"2020-01-11T04:03:00+00:00","dateModified":"2021-05-13T22:04:26+00:00","breadcrumb":{"@id":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sfj-pharma.com\/phas-stock-rockets-25-on-collaboration-with-sfj-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sfj-pharma.com\/"},{"@type":"ListItem","position":2,"name":"PHAS Stock Rockets 25% on Collaboration With SFJ Pharma"}]},{"@type":"WebSite","@id":"https:\/\/www.sfj-pharma.com\/#website","url":"https:\/\/www.sfj-pharma.com\/","name":"SFJ Pharmaceuticals","description":"Resources for Accelerated Clinical Development","publisher":{"@id":"https:\/\/www.sfj-pharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sfj-pharma.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.sfj-pharma.com\/#organization","name":"SFJ Pharmaceuticals","url":"https:\/\/www.sfj-pharma.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552","contentUrl":"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552","width":750,"height":205,"caption":"SFJ Pharmaceuticals"},"image":{"@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/770e5cbce35f5f0f90d2218806ceba11","name":"Lily Xu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2b733936c0f668be1f942765f61e3056?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2b733936c0f668be1f942765f61e3056?s=96&d=mm&r=g","caption":"Lily Xu"},"url":"https:\/\/www.sfj-pharma.com\/author\/lily\/"}]}},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"Lily Xu","author_link":"https:\/\/www.sfj-pharma.com\/author\/lily\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.sfj-pharma.com\/category\/news\/\" rel=\"category tag\">News<\/a>","rttpg_excerpt":"In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that it\u00a0reached a collaboration\u00a0and financing agreement with SFJ, which has had...","_links":{"self":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts\/7479"}],"collection":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/comments?post=7479"}],"version-history":[{"count":2,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts\/7479\/revisions"}],"predecessor-version":[{"id":8459,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts\/7479\/revisions\/8459"}],"wp:attachment":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/media?parent=7479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/categories?post=7479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/tags?post=7479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}